Health economics is about making choices under constraints
View in browser
Office of Health Economics | OHE

The Bulletin

Your biweekly update on health economics, policy, and impact

We look at China’s HTA journey, the economic toll of respiratory infections on employers, and a new way to understand healthcare system pressure:

  • Around the world in HTAs: China – From fragmentation to function
  • Employer costs from respiratory infections
  • Developing a conceptual framework of healthcare system pressure

Short on time? Catch us in the next Bulletin. Got a minute? Take a closer look.

Simon Brassel

Simon Brassel, Senior Principal Economist

Health economics is about making choices under constraints

In practice, its application relies on many factors such as processes & institutions, data & evidence and methods & frameworks. In this month’s bulletin, we highlight three recent pieces of OHE’s work that reflect these dimensions

 

How do you decide what to buy with the ~2% of GDP spent on prescription drugs when you aim to improve the health of 1.4 billion citizens? This question is explored in the most recent edition of our Around the World in HTAs blog series. Follow Meng, Claud, and Yawen on China’s journey of HTA capacity building and better decision-making.

 

We assessed UK employers’ productivity losses due to seasonal respiratory infections. OHE estimate these cause losses of £44 billion each year, highlighting the strong link between health and wealth and the potential value that increased workplace immunisation programmes could generate.

 

Over a year ago, we developed a framework to define health system pressure, which in most health systems is still omnipresent. Recent headlines, such as an AI physio app that halves the NHS backlog for physiotherapy appointments, are examples of how investments can increase usable capacity of staff and therefore eases health system pressure.

 

How China’s health system is reshaping access to medicines

Around the world in HTAs: China – From fragmentation to function

China has transformed its approach to drug reimbursement, moving from infrequent and unclear updates of its national drug list to an evidence-based, annual process overseen by the National Healthcare Security Administration. Since 2017, more than 700 new medicines, including many innovative therapies, have been added through structured HTA-driven negotiations. While progress is clear, challenges remain around transparency, data quality, and the expansion of HTA to devices and digital health.

What's next for HTA in China?

Respiratory infections could be cost UK businesses £44bn a year

Employer Costs from Respiratory Infections

 

Respiratory infections cost UK businesses an estimated £44 billion annually, with most losses coming from presenteeism. Women and certain industries are disproportionately affected, highlighting both productivity and equity challenges. The report shows how employer-led vaccination programs and supportive policy measures could reduce costs, strengthen workforce health, and boost economic growth.

See how prevention could save businesses billions

A new framework to measure healthcare system pressure

Developing a Conceptual Framework of Healthcare System Pressure

 

Our conceptual framework defines Healthcare System Pressure (HCSP) as demand exceeding usable capacity, introduces ways to measure it, and highlights strategies to anticipate or mitigate pressure. This framework offers policymakers and HTA bodies a shared language and practical tool for evaluating interventions that strengthen healthcare resilience.

See how the framework supports better health policy

As an employer, have you considered the impact of respiratory infections on productivity? 

 

A new interactive Respiratory Cost Calculator, developed by OHE, commissioned and owned by Pfizer, enables employers to estimate the financial impact of absenteeism and presenteeism due to short-term respiratory illnesses.

 

Job code: PP-UNP-GBR-12608 June 2025

 

Calculate now

If you’ve made it to the end and enjoyed this edition, hit reply and share one insight that stood out to you.

Office of Health Economics | OHE

Office of Health Economics, 2nd Floor Goldings House, Hay's Galleria, 2 Hay's Lane, Southwark, London SE1 2HB, United Kingdom, +44 (0) 20 7747 8850

Unsubscribe Manage preferences

LinkedIn
BlueSky
X
Website